Key details
Phase
Early testing / Safety & dosing
Sponsor
University Hospital, Lille
Collaborators
InBrain Pharma
Enrollment target
~1 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated October 2025